Natera, Inc. NTRA Licensing and other revenues — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Natera, Inc.'s licensing and other revenues — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Natera, Inc.'s licensing and other revenues — total revenues?
- Natera, Inc. (NTRA) reported licensing and other revenues — total revenues of $2.78M in Q1 2026.
- How has Natera, Inc.'s licensing and other revenues — total revenues changed year-over-year?
- Natera, Inc.'s licensing and other revenues — total revenues increased by 54.7% year-over-year, from $1.79M to $2.78M.
- What is the long-term trend for Natera, Inc.'s licensing and other revenues — total revenues?
- Over 4 years (2021 to 2025), Natera, Inc.'s licensing and other revenues — total revenues has grown at a -31.0% compound annual growth rate (CAGR), from $45.41M to $10.29M.
- What does licensing and other revenues — total revenues mean?
- This metric represents the total revenue generated from licensing proprietary molecular and bioinformatics technology, intellectual property, and associated service agreements. It reflects the company's ability to monetize its research and development pipeline through partnerships and external commercialization efforts beyond its core diagnostic testing services. This revenue stream is a key indicator of the company's technological leadership and its success in leveraging intellectual assets to drive non-core growth.